Shares of SLM Corporation (NASDAQ:SLM) opened at $10.59, and ended -1.04% lower at $10.49. Nearly 2.25 million shares were traded by the close, lower than its average daily volume of 2.53 million shares. SLM Corporation has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 4.07% of shares outstanding. The stock sank -2.69% last month and is down -4.81 this year. Wall Street is only getting more bullish on the stock, with 9 of analysts who cover SLM having a buy-equivalent rating. Analysts have placed a $14.2 price target on SLM Corporation, suggesting a 35.37% gain from recent close. It’s currently trading about -20.53% below its 52-week high. SLM Corporation (SLM) failed to surprise the stock market in its last reported earnings when it earned $0.17 a piece versus the consensus-estimated $0.17. Its revenue totaled $282.92 million up 4.83% from the previous quarter.  This stock (SLM) is ahead of its 52-week low with 9.16%. Its last month’s stock price volatility remained 2.14% which for the week stands at 2.63%. The share price has moved forward from its 20 days moving average, trading at a distance of 1.19% and stays -2.62% away from its 50 days moving average. Over the last five days, shares have managed 1.55% gains and now is down -6.29% since hitting its 200-day moving average of $10.79. SLM Corporation (SLM) has made its way to a 12-month gain of 7.59%. Turning to Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), its shares were trading at $107.75 a retreat of $-0.86, on the trading floor. The stock, after opening at $108.64, touched a high of $110.91 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.9. Alexion Pharmaceuticals, Inc. has 7 buy ratings, 3 holds and 0 sells even after the stock tumbled -27.85% from its high of $149.34 to a $24.03 billion market value through last close. The company’s consensus rating on Reuter’s scale remained unchanged from 1.81 to 1.81 during a month. Analysts set a 12-month price target of $163.43 a share. The target implies a 51.68% spike from where the shares are currently trading. Also, the current price highlights a discount of 67.05% to analysts’ high consensus price target. The counter witnessed a trading volume of 2.13 million shares versus an average volume of 1.91 million shares during last trading session. Its last month’s stock price volatility remained 2.09% which for the week approaches 2.86%. The lowest price the stock reached in the last trading day was $107.22 and compares with the $96.18 52-week low. The stock recovered 12.03% since its low point and has performed -11.93% year-to-date.